Microsoft to Lay Off 3% of Global Workforce
May 14, 2025: Microsoft has announced plans to reduce its global workforce by approximately 3%, affecting roughly 10,000 employees across multiple departments.
- May 18, 2025 3:32 am
- California
April 26, 2021: – A single dose of Oxford-AstraZeneca or Pfizer-BioNTech’s Covid-19 vaccine reduces the risk of infection in adults of all ages drastically, British researchers have found.
Two studies released on Friday analyzed over 1.6 million nose and throat swabs were taken from 373,402 people between December and April. The data was collected as part of the ongoing Covid-19 Infection Survey, carried out by the University of Oxford, the Office of National Statistics, and the Department for Health and Social Care of the U.K.
Researchers found that 21 days after a single dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine, new Covid infections, both symptomatic and asymptomatic, fell by 65%.
Symptomatic infections fell by 74% three weeks after a single dose of either vaccine, while asymptomatic cases were down by 57%, the data showed.
A second vaccine dose reduced the overall infection rate by 70%, with symptomatic Covid infections down by 90% and asymptomatic cases of the virus cut by 49%. Researchers likened these effects to the natural immunity gained from being infected with the virus.
Vaccines had a similar effect in adults of all ages when it came to reducing infection rates; the study found their ability to reduce infections also identical regardless of whether participants had long-term health conditions.
Scientists also examined the impact Covid vaccinations had on participants’ antibody levels. They found that older adults significantly above 60 who had never contracted Covid had a lower immune response to a single vaccine dose than those infected with the virus before.
Antibody responses to two doses of the Pfizer-BioNTech vaccine were high across all age groups. Data showed that older adults could reach similar antibody levels to those who had received one vaccine dose after a previous Covid infection.
Antibody levels rose more slowly following a single dose of the Oxford-AstraZeneca vaccine than the Pfizer-BioNTech alternative. However, antibody levels dropped more quickly following an amount of the latter, particularly in older adults, so that patients reached similar levels of antibodies to those seen after a first shot of the Oxford-AstraZeneca vaccine.
We provide the insights on leaders who are responsible for taking their organization to new heights, all the while bringing together a group of talented individuals.
May 14, 2025: Microsoft has announced plans to reduce its global workforce by approximately 3%, affecting roughly 10,000 employees across multiple departments.
May 13, 2025: The Trump administration is considering suspending the constitutional right of habeas corpus in a bid to accelerate mass deportations.
April 29, 2025: Donald Trump’s second term has reached the 100-day mark under sustained public skepticism, with national approval ratings
April 24, 2025: NATO closely monitors a series of Russian naval exercises in the northern waters near Finland and Norway amid heightened military activity
April 23, 2025: The U.S. Supreme Court is preparing to issue a ruling on whether AI-generated political speech is protected under the First Amendment
Manufacturers often struggle with generating accurate and timely quotes, delaying customer responses and risking profitability. Traditional quoting processes can take days or even weeks, while customers expect responses within 24 hours. Micro Estimating Systems addresses these challenges with advanced software that allows users to generate highly accurate quotes in minutes. By integrating with shop-specific data and automating feature recognition, their solutions ensure precision and speed, empowering manufacturers to make informed decisions and enhance their operational efficiency.